Stem cell therapy for corneal damage represents a groundbreaking advancement in ocular medicine, specifically in addressing injuries that previously left patients with permanent vision impairment.This innovative approach leverages cultivated autologous limbal epithelial cells (CALEC) to restore the corneal surface, offering new hope for those suffering from conditions like chemical burns and infections.